Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Barth, M; Xavier, AC; Armenian, S; Audino, AN; Blazin, L; Bloom, D; Chung, J; Davies, K; Ding, H; Ford, JB; Galardy, PJ; Hanna, R; Hayashi, R ...
Published in: J Natl Compr Canc Netw
November 2022
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
November 2022
Volume
20
Issue
11
Start / End Page
1267 / 1275
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Medical Oncology
- Lymphoma, Large B-Cell, Diffuse
- Humans
- Child
- Adolescent
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Barth, M., Xavier, A. C., Armenian, S., Audino, A. N., Blazin, L., Bloom, D., … Sundar, H. (2022). Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 20(11), 1267–1275. https://doi.org/10.6004/jnccn.2022.0057
Barth, Matthew, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, et al. “Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 20, no. 11 (November 2022): 1267–75. https://doi.org/10.6004/jnccn.2022.0057.
Barth M, Xavier AC, Armenian S, Audino AN, Blazin L, Bloom D, et al. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Nov;20(11):1267–75.
Barth, Matthew, et al. “Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 20, no. 11, Nov. 2022, pp. 1267–75. Pubmed, doi:10.6004/jnccn.2022.0057.
Barth M, Xavier AC, Armenian S, Audino AN, Blazin L, Bloom D, Chung J, Davies K, Ding H, Ford JB, Galardy PJ, Hanna R, Hayashi R, Lee-Miller C, Machnitz AJ, Maloney KW, Marks L, Martin PL, McCall D, Pacheco M, Reilly AF, Roshal M, Song S, Weinstein J, Zarnegar-Lumley S, McMillian N, Schonfeld R, Sundar H. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Nov;20(11):1267–1275.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
November 2022
Volume
20
Issue
11
Start / End Page
1267 / 1275
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Medical Oncology
- Lymphoma, Large B-Cell, Diffuse
- Humans
- Child
- Adolescent
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis